BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 28814333)

  • 1. Rapamycin Prevents cyclophosphamide-induced Over-activation of Primordial Follicle pool through PI3K/Akt/mTOR Signaling Pathway in vivo.
    Zhou L; Xie Y; Li S; Liang Y; Qiu Q; Lin H; Zhang Q
    J Ovarian Res; 2017 Aug; 10(1):56. PubMed ID: 28814333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Mullerian hormone attenuates both cyclophosphamide-induced damage and PI3K signalling activation, while rapamycin attenuates only PI3K signalling activation, in human ovarian cortex in vitro.
    Rosario R; Stewart HL; Spears N; Telfer EE; Anderson RA
    Hum Reprod; 2024 Feb; 39(2):382-392. PubMed ID: 38070496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual suppression of follicle activation pathways completely prevents the cyclophosphamide-induced loss of ovarian reserve.
    Kashi O; Roness H; Spector I; Derech-Haim S; Meirow D
    Hum Reprod; 2023 Jun; 38(6):1086-1098. PubMed ID: 37015102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin preserves the primordial follicle pool during cisplatin treatment in vitro and in vivo.
    Xie Y; Li S; Zhou L; Lin H; Jiao X; Qiu Q; Liang Y; Zhang Q
    Mol Reprod Dev; 2020 Apr; 87(4):442-453. PubMed ID: 32112509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quercetin prevents primordial follicle loss via suppression of PI3K/Akt/Foxo3a pathway activation in cyclophosphamide-treated mice.
    Li J; Long H; Cong Y; Gao H; Lyu Q; Yu S; Kuang Y
    Reprod Biol Endocrinol; 2021 Apr; 19(1):63. PubMed ID: 33892727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapamycin prevents cyclophosphamide-induced ovarian follicular loss and potentially inhibits tumour proliferation in a breast cancer xenograft mouse model.
    Tanaka Y; Amano T; Nakamura A; Yoshino F; Takebayashi A; Takahashi A; Yamanaka H; Inatomi A; Hanada T; Yoneoka Y; Tsuji S; Murakami T
    Hum Reprod; 2024 May; ():. PubMed ID: 38734930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dingkun Pill replenishes diminished ovarian reserve through the PI3K/AKT/mTOR signaling pathway in TWP-induced mice.
    Ma K; Chen Y; Fan X; Yuan Y; Wang K; Tian C; Li M
    J Ethnopharmacol; 2020 Nov; 262():112993. PubMed ID: 32473368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electro-acupuncture attenuates the mice premature ovarian failure via mediating PI3K/AKT/mTOR pathway.
    Zhang H; Qin F; Liu A; Sun Q; Wang Q; Xie S; Lu S; Zhang D; Lu Z
    Life Sci; 2019 Jan; 217():169-175. PubMed ID: 30521869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follicle Loss and Apoptosis in Cyclophosphamide-Treated Mice: What's the Matter?
    Chen XY; Xia HX; Guan HY; Li B; Zhang W
    Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27248997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of PI3K and Hippo signaling pathways during in vitro human follicle activation.
    Grosbois J; Demeestere I
    Hum Reprod; 2018 Sep; 33(9):1705-1714. PubMed ID: 30032281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin maintains the primordial follicle pool and protects ovarian reserve against cyclophosphamide-induced damage.
    Chen X; Tang Z; Guan H; Xia H; Gu C; Xu Y; Li B; Zhang W
    J Reprod Dev; 2022 Aug; 68(4):287-294. PubMed ID: 35718464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclophosphamide triggers follicle activation and "burnout"; AS101 prevents follicle loss and preserves fertility.
    Kalich-Philosoph L; Roness H; Carmely A; Fishel-Bartal M; Ligumsky H; Paglin S; Wolf I; Kanety H; Sredni B; Meirow D
    Sci Transl Med; 2013 May; 5(185):185ra62. PubMed ID: 23677591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [p53 regulates primordial follicle activation through the mTOR signaling pathway].
    Lin H; Ren TH; Tong YT; Wu GF; Zhang T; Chen TX; Xu GQ
    Sheng Li Xue Bao; 2023 Jun; 75(3):339-350. PubMed ID: 37340643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin: a novel promising option for fertility preservation during cyclophosphamide-based chemotherapy.
    Huang CC; Chou CH; Yang YS; Ho HN; Shun CT; Wen WF; Chen SU; Chen MJ
    Mol Hum Reprod; 2021 Jan; 27(1):. PubMed ID: 33543290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice.
    Sonigo C; Beau I; Grynberg M; Binart N
    FASEB J; 2019 Jan; 33(1):1278-1287. PubMed ID: 30113879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin preserves the follicle pool reserve and prolongs the ovarian lifespan of female rats via modulating mTOR activation and sirtuin expression.
    Zhang XM; Li L; Xu JJ; Wang N; Liu WJ; Lin XH; Fu YC; Luo LL
    Gene; 2013 Jul; 523(1):82-7. PubMed ID: 23566837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zihuai recipe alleviates cyclophosphamide-induced diminished ovarian reserve via suppressing PI3K/AKT-mediated apoptosis.
    Liu W; Chen Q; Liu Z; Weng Z; Nguyen TN; Feng J; Zhou S
    J Ethnopharmacol; 2021 Sep; 277():113789. PubMed ID: 33422655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological inhibition of mTORC1 prevents over-activation of the primordial follicle pool in response to elevated PI3K signaling.
    Adhikari D; Risal S; Liu K; Shen Y
    PLoS One; 2013; 8(1):e53810. PubMed ID: 23326514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin-sensitive mTORC1 signaling is involved in physiological primordial follicle activation in mouse ovary.
    Tong Y; Li F; Lu Y; Cao Y; Gao J; Liu J
    Mol Reprod Dev; 2013 Dec; 80(12):1018-34. PubMed ID: 24123525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New strategy for in vitro activation of primordial follicles with mTOR and PI3K stimulators.
    Sun X; Su Y; He Y; Zhang J; Liu W; Zhang H; Hou Z; Liu J; Li J
    Cell Cycle; 2015; 14(5):721-31. PubMed ID: 25590233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.